Abstract
Lewin I(3, and O'Riordan JLH: 1,25-Dihydroxycholecalciferol in the pathogenesis of the hypercalcemia of sarcoidosis, Lancet 4:627, 1979. 6. Barbour GL, Coburn JW, Norman AW, and Slatopolsky E: Non-renal hypercalcemia in sarcoidosis, Clin Res 28:46A, 1980. 7. Arnaud CD, Tsao HS, and Littledike T: Radioimmunoassay of human parathyroid hormone in serum, J Clin Invest 50:21, 1971. 8. Shepard RM, Horst RL, Hamstra AJ, and DeLuca HF: Determination of vitamin D and its metabolites in plasma from normal and anephric man, Biochem J 182:55, 1979. 9. Rice L, Laughter AH, and Twomey JJ: Three suppressor systems in human blood that modulate lymphoproliferation, J lmmunol 122:991, 1979. 10. Chesney RW, Rosen JE, Hamstra A, and DeLuca HF: Serum 1,25-dihydroxyvitamin D~ levels in normal children and in disorders of vitamin D metabolism, Am J Dis Child 134:135, 1980. 11. Spagnuolo PJ, Ellner JJ, Bouknight RB, Tomford JW, Kleinhenz ME, and Edmonds KL: Interrelationships of immunoregulatory cells and serum factors in sarcoidosis, J Immunol 125:1071, 1980. 12. Broadus AE, Horst RL, Lang R, Littledike ET, and Rasmussen H: The importance of circulating 1,25-dihydroxyvitamin D in the pathogenesis of hypercalcuria and renalstone formation in primary hyperparathyroidism, N Engl J Med 302:421, t980. 13. Chesney RW, Mazess RB, Hamstra AJ, and DeLuca HF: Reduction of serum 1,25-dihydroxyvitamin D~ levels in children receiving glucocorticosteroids, Lancet 2:1123, 1978. 14. O'Regan S, Chesney RW, Hamstra A J, Eisman JA, O'Gorman AM, and DeLuca HF: Reduced serum 1,25-dihydroxyvitamin D3 levels in adolescents with systemic lupus erythematosus, Acta Pediatr Scand 68:109, 1979. 15. Seeman E, Kumar R, Hunder GG, Scott M, Heath H, and Riggs BL: Production, degradation and circulating levels of 1,25-dihydroxyvitamin D in health and in chronic glucocorticoid excess, J Clin Invest 66:664, 1980. 16. Zerwekh JE, Pak CYC, Kaplan RA, McGuire JL, Upchurch K, Breslau N, and Johnson R Jr: Pathogenic role of la, 25-dihydroxyvitamin D in sarcoidosis and absorptive hypercalcuria: Different response to prednisone therapy, J Clin Endocrinol Metab 51:381, 1980.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
